The role of the tumor stroma in ovarian cancer

被引:43
作者
Davidson, Ben [1 ,2 ]
Trope, Claes G. [2 ,3 ]
Reich, Reuven [4 ]
机构
[1] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Pathol, N-0424 Oslo, Norway
[2] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway
[3] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Gynecol Oncol, Oslo, Norway
[4] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Inst Drug Res, Jerusalem, Israel
关键词
ovarian carcinoma; stromal myofibroblasts; metastasis; tumor progression; prognosis;
D O I
10.3389/fonc.2014.00104
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The tumor microenvironment, consisting of stromal myofibroblasts, endothelial cells, and leukocytes, is growingly perceived to be a major contributor to the pathogenesis and disease progression in practically all cancer types. Stromal myofibroblasts produce angiogenic factors, proteases, growth factors, immune response-modulating proteins, anti-apoptotic proteins, and signaling molecules, and express surface receptors and respond to stimuli initiated in the tumor cells to establish a bi-directional communication network in the microenvironment to promote tumor cell invasion and metastasis. Many of these molecules are candidates for targeted therapy and the cancer stroma has been recently regarded as target for biological intervention. This review provides an overview of the biology and clinical role of the stroma in ovarian cancer.
引用
收藏
页数:11
相关论文
共 142 条
[1]
Immunolocalization of nuclear transcription factors, DAX-1 and Ad4BP/SF-1, in human common epithelial ovarian tumors: Correlations with StAR and steroidogenic enzymes in epithelial ovarian carcinoma [J].
Abd-Elaziz, M ;
Moriya, T ;
Akahira, J ;
Nakamura, Y ;
Suzuki, T ;
Sasano, H .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2005, 24 (02) :153-163
[2]
Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis [J].
Acquati, Francesco ;
Lualdi, Marta ;
Bertilaccio, Sabrina ;
Monti, Laura ;
Turconi, Giovanna ;
Fabbri, Marco ;
Grimaldi, Annalisa ;
Anselmo, Achille ;
Inforzato, Antonio ;
Collotta, Angelo ;
Cimetti, Laura ;
Riva, Cristina ;
Gribaldo, Laura ;
Ghia, Paolo ;
Taramelli, Roberto .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (20) :8140-8145
[3]
Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas [J].
Afify, AM ;
Ferguson, AW ;
Davila, RM ;
Werness, BA .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2001, 9 (04) :309-314
[4]
MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: Possible implications for the role of desmoplastic fibroblasts [J].
Afzal, S ;
Lalani, EN ;
Poulsom, R ;
Stubbs, A ;
Rowlinson, G ;
Sato, H ;
Seiki, M ;
Stamp, GWH .
HUMAN PATHOLOGY, 1998, 29 (02) :155-165
[5]
Afzal S, 1996, LAB INVEST, V74, P406
[6]
An immunohistochemical perspective of PPARβ and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours [J].
Ahmed, N. ;
Riley, C. ;
Quinn, M. A. .
BRITISH JOURNAL OF CANCER, 2008, 98 (08) :1415-1424
[7]
Differential Roles of uPAR in Peritoneal Ovarian Carcinomatosis [J].
Al-Hassan, Nada N. ;
Behzadian, Ali ;
Caldwell, Ruth ;
Ivanova, Vessela S. ;
Syed, Viqar ;
Motamed, Kouros ;
Said, Neveen A. .
NEOPLASIA, 2012, 14 (04) :259-+
[8]
Anttila MA, 2000, CANCER RES, V60, P150
[9]
Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma [J].
Arts, HJG ;
de Jong, S ;
Hollema, H ;
ten Hoor, K ;
van der Zee, AGJ ;
de Vries, EGE .
GYNECOLOGIC ONCOLOGY, 2004, 92 (03) :794-800
[10]
AUTIOHARMAINEN H, 1993, LAB INVEST, V69, P312